Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caitlin Costello

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Cell Stem Cell|January 21, 2021
Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruptionPhoebe K Mondala, Ashni A Vora, Tianyuan Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2025
Expert Perspectives on Current Challenges and Emerging Approaches for Multiple Myeloma: Narrative Review of an Inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple MyelomaAjai Chari, Susan Bal, Sikander Ailawadhi, et al.
American Journal of Hematology|April 21, 2026
Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps ConferenceAjai Chari, Caitlin Costello, Amrita Krishnan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 2, 2023
Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myelomaCarolyn Rath, Claude Yoo, Halle Cheplowitz, et al.
Hematology (Amsterdam, Netherlands)|July 8, 2022
Extracorporeal photopheresis for the treatment of chronic graft versus host diseaseEmin Kansu, David Ward, Amber P Sanchez, et al.
Nature Communications|December 6, 2017
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myelomaElisa Lazzari, Phoebe K Mondala, Nathaniel Delos Santos, et al.
Blood Advances|June 24, 2025
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abataceptDivya Koura, Kaitlyn Dykes, Aaron Goodman, et al.
Future Oncology (London, England)|March 1, 2019
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myelomaCaitlin Costello, Faith E Davies, Gordon Cook, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2023
Heart-liver-kidney transplantation for AL amyloidosis using normothermic recovery and storage from a donor following circulatory death: Short-term outcome in a first-in-world experienceAleah L Brubaker, Marcus A Urey, Raeda Taj, et al.
Blood Cancer Journal|October 6, 2025
Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analysesLaahn Foster, Larry D Anderson, Alfred Chung, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Cell Stem Cell|January 21, 2021
Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruptionPhoebe K Mondala, Ashni A Vora, Tianyuan Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2025
Expert Perspectives on Current Challenges and Emerging Approaches for Multiple Myeloma: Narrative Review of an Inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple MyelomaAjai Chari, Susan Bal, Sikander Ailawadhi, et al.
American Journal of Hematology|April 21, 2026
Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps ConferenceAjai Chari, Caitlin Costello, Amrita Krishnan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 2, 2023
Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myelomaCarolyn Rath, Claude Yoo, Halle Cheplowitz, et al.
Hematology (Amsterdam, Netherlands)|July 8, 2022
Extracorporeal photopheresis for the treatment of chronic graft versus host diseaseEmin Kansu, David Ward, Amber P Sanchez, et al.
Nature Communications|December 6, 2017
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myelomaElisa Lazzari, Phoebe K Mondala, Nathaniel Delos Santos, et al.
Blood Advances|June 24, 2025
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abataceptDivya Koura, Kaitlyn Dykes, Aaron Goodman, et al.
Future Oncology (London, England)|March 1, 2019
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myelomaCaitlin Costello, Faith E Davies, Gordon Cook, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2023
Heart-liver-kidney transplantation for AL amyloidosis using normothermic recovery and storage from a donor following circulatory death: Short-term outcome in a first-in-world experienceAleah L Brubaker, Marcus A Urey, Raeda Taj, et al.
Blood Cancer Journal|October 6, 2025
Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analysesLaahn Foster, Larry D Anderson, Alfred Chung, et al.
Pageof 6